Anant Mandawat, MD

Dr. Mandawat specializes in cutting-edge techniques to detect cardiac disease early and prevent complications that may result before, during, or after cancer treatment.

Titles and Roles

Assistant Professor, Department of Hematology and Medical Oncology: Emory University School of Medicine
Assistant Professor, Division of Cardiology, Department of Medicine: Emory University School of Medicine
Director, Cardio-Oncology Program: Winship Cancer Institute of Emory University

Cardio-Oncologist: Cardio-Oncology Clinic; Cardiac Tumors

Research Program: Cancer Prevention and Control

Biography

Anant Mandawat, MD, serves as the director of Cardio-Oncology at Winship Cancer Institute of Emory University, and holds joint appointments as assistant professor in the Department of Hematology and Medical Oncology and in the Division of Cardiology of the Department of Internal Medicine at Emory University School of Medicine. In addition, he co-leads Emory’s multidisciplinary Cardiac Tumor Program which assess and treats masses in the heart.

A cardio-oncologist, Dr. Mandawat is an expert in the early detection, prevention, and treatment of cardiac diseases in patients with cancer. He specializes in cutting-edge techniques to detect cardiac disease early and prevent complications that may result before, during, or after cancer treatment. He has a clinical interest in long-term cardiac risk assessment and follow-up in cancer survivors. He has received advanced training with a specialized fellowship in cardiovascular imaging. He is board-certified in Internal Medicine and Cardiovascular Disease, and has additional board certifications in Echocardiography, and Nuclear Cardiology.

Dr. Mandawat is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute of Emory Unviersity. He holds professional membership in the American College of Cardiology (ACC) and serves on the ACC's Cardiovascular Management Leadership Council.

Education

Dr. Mandawat graduated with a medical degree with honors from Yale School of Medicine in New Haven, Connecticut. He completed his internal medicine residency at Massachusetts General Hospital/Harvard Medical School in Boston, Massachusetts. He then completed his fellowship in cardiology at Duke University Medical Center in Durham, North Carolina where he focused on cardio-oncology and advanced cardiovascular imaging.

Research

Dr. Mandawat's research focuses on cardiac outcomes of patients with cancer. He is a leader in cardiovascular toxicity from prostate cancer treatments. He co-leads the Cardio-Oncology PROstate Cancer (CO-PRO) biobank, a prospective translational biobank using immunomics, genomics, and proteomics to better understand mechanisms and risk stratification of cardiovascular toxicity from androgen deprivation therapy.

Publications

Dr. Mandawat has authored numerous peer-reviewed publications and his work has been presented at multiple national meetings. He serves as a manuscript reviewer for cardiology and oncology publications including the Journal of the American College of Cardiology (JACC), JACC Heart Failure, JACC CardioOncology, Cancer, and JCO Oncology Practice. He places a strong emphasis on patient communication and patient-centered care and has served as a contributing editor for Harvard Health Publications and a medical columnist for The Augusta Chronicle.

Publications Publication Date

Awards

Dr. Mandawat was selected to the 2019 Class of 40 Under 40 University of Georgia Alumni and 40 Under 40 Rising Stars & Emerging Leaders in Cancer Award. He has also received the Farr Award, the Dr. Marvin Moser Award, and the Bechtel Award for his contributions in research.